Gastroesophageal reflux and prokinetic agents.
Hammer
Davita
D
St. Luke's Hospital, Kansas City, Missouri, USA.
D018723:Bethanechol / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004917:Erythromycin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005764:Gastroesophageal Reflux / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy; D005765:Gastrointestinal Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D008787:Metoclopramide / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D018721:Muscarinic Agonists / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D005765:Gastrointestinal Agents; D018721:Muscarinic Agonists; D018723:Bethanechol; D004917:Erythromycin; D008787:Metoclopramide